Contributions

  • Vanchieri, Cori. - Contributor
  • Butler, Adrienne Stith. - Contributor
  • Knutsen, Andrea. - Contributor
  • Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. - Contributor

Publication

2008 - National Academies Press, Washington, D.C, District of Columbia

Language

English

Word Count

13,000 words, Guess

Page Count

52 pages

Identifiers

  • ISBN-100309107423
  • ISBN-139780309107426
  • Library of Congress Control Number2009285666
  • OCLC Control Number252584123
  • Better World Books9780309107426
and 1 more

Classifications

  • LCCRJ560 .A33 2008

Description

Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.

Subjects

Topics

DrugsTestingResearchStandardsCongressesPediatricsDrugs, testing

Places

Genres

  • Congresses

Links

Other Editions

  • Addressing the barriers to pediatric drug development: workshop summaryNational Academies Press2008-01-01

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!